The average target price for Clover Health Investments (CLOV) stock is $4.23. This projection suggests a notable potential upside from its last trading price.
Understanding Stock Price Targets
A stock price target represents an analyst's forecast of a security's future price. These targets are typically derived from various analytical methods, including financial modeling, market analysis, and assessment of company fundamentals and industry trends. They serve as a benchmark for investors, indicating what analysts believe a stock is worth and where its price might head over a specific period, often 12 months.
Detailed Price Targets for CLOV
Analysts have provided a range of price targets for Clover Health Investments (CLOV), reflecting their varying outlooks on the company's future performance and market position. The average target provides a consensus view, while the high and low forecasts illustrate the breadth of analyst expectations.
Here's a breakdown of the price targets for CLOV:
Metric | Value |
---|---|
Average Price Target | $4.23 |
High Forecast | $4.50 |
Low Forecast | $4.00 |
Last Trading Price | $3.17 |
Potential Change from Last Price | 33.44% |
This average target price of $4.23 indicates a potential increase of 33.44% from the last recorded price of $3.17.
What These Targets Mean for Investors
- Consensus View: The average price target of $4.23 reflects the general sentiment among analysts, suggesting a belief in the stock's growth potential.
- Potential Upside: A 33.44% potential change indicates that analysts foresee significant appreciation from the stock's current valuation.
- Range of Opinions: The spread between the high forecast of $4.50 and the low forecast of $4.00 highlights that while there's a general positive outlook, individual analysts may have different levels of optimism or concern regarding the stock's future.
- Informative, Not Guaranteed: It's important for investors to remember that price targets are forecasts and not guarantees. They should be used as one component of a comprehensive investment research process, alongside fundamental analysis of the company, market conditions, and personal financial goals.